Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2026-04-06 @ 10:53 AM
Study NCT ID:
NCT00549757
Status:
TERMINATED
Last Update Posted:
2014-04-21
First Post:
2007-10-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10
Start Date Type:
None
Primary Completion Date:
2013-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-24
First Submit QC Date:
None
Study First Post Date:
2007-10-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-02-03
Results First Submit QC Date:
None
Results First Post Date:
2014-03-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-04-01
Last Update Post Date:
2014-04-21
Last Update Post Date Type:
ESTIMATED